Invention Grant
- Patent Title: Use of gp130 activators in diabetic neuropathy
- Patent Title (中): 在糖尿病性神经病变中使用gp130激活剂
-
Application No.: US12754335Application Date: 2010-04-05
-
Publication No.: US08278286B2Publication Date: 2012-10-02
- Inventor: Michel Dreano , Pierre-Alain Vitte
- Applicant: Michel Dreano , Pierre-Alain Vitte
- Applicant Address: CH Coinsins, Vaud
- Assignee: Merck Serono SA
- Current Assignee: Merck Serono SA
- Current Assignee Address: CH Coinsins, Vaud
- Agency: Browdy and Neimark, PLLC
- Priority: EP01123400 20011011
- Main IPC: A61K48/00
- IPC: A61K48/00 ; A01N63/00
Abstract:
The invention relates to the use a substance signaling through gp130 for the manufacture of a medicament for the treatment and/or prevention of diabetic neuropathy. The use of IL-6 is preferred.
Public/Granted literature
- US20100189684A1 USE OF gp130 ACTIVATORS IN DIABETIC NEUROPATHY Public/Granted day:2010-07-29
Information query
